Remove Genetic Disease Remove In-Vitro Remove In-Vivo Remove Life Science
article thumbnail

€2m raised in seed funding to develop novel therapies for Cystic Fibrosis  

Drug Discovery World

This investment from the AFB FII fund stems from the AdBio-Inserm Transfert partnership announced in May 2022 to finance, support and grow Europe’s most innovative life science startups. Anoat will use the funds to conduct additional in vivo and in vitro pharmacology assessments and select a lead candidate.

article thumbnail

Transitioning Between Academia and Industry: Advice from Leading Scientists That Made the Switch

XTalks

A life-changing moment came for Dr. Leaving academia for industry is a route that academic scientists and professors did not traditionally pursue in the past due to perceived differences in skillsets, experiences and even associated stigmas. The journey first starts with the decision to make the switch. Key Moments.